Insulin pen production facility for Sanofi

Location: Industriepark Höchst

Sanofi, one of the world's leading pharmaceutical companies, was planning the construction of a new production facility for insulin pens – the products would be assembled and packaged in four halls. It also required testing labs, administrative offices, an incoming goods center, a high-bay warehouse and a temperature-controlled storage aisle. Infraserv Höchst completed the project in a record-breaking 15 months without interrupting operations and demonstrated world-class expertise in design, permitting, construction and operation.

Our services:

  • Developing a facility management system to support GMP-compliant operation
  • Developing an implementation strategy from the trial run to regular operation
  • Quality management and auditing
  • End-to-end operation, including heating, ventilation and air-conditioning (HVAC), utilities, waste management and plant management

FACTS AND FIGURES
Total area: 28,000 m2, 15,000 positions in the high-bay warehouse, production volume: approx. 100 mn insulin pens/year

Customer service

Hotline
+49 69 305-6767
Monday - Friday
8:00 - 17:00 h
Hotline